Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
medical procedure
|
| gptkbp:alternativeTo |
gptkb:PCSK9_inhibitors
statin therapy |
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:duration |
2-4 hours per session
|
| gptkbp:effect |
reduces cardiovascular risk
|
| gptkbp:frequency |
every 1-2 weeks
|
| https://www.w3.org/2000/01/rdf-schema#label |
LDL apheresis
|
| gptkbp:indication |
patients with high LDL unresponsive to medication
|
| gptkbp:introducedIn |
1970s
|
| gptkbp:performedAt |
specialized medical centers
|
| gptkbp:performedBy |
trained healthcare professionals
|
| gptkbp:removes |
gptkb:low-density_lipoprotein_(LDL)
apolipoprotein B-containing lipoproteins |
| gptkbp:requires |
venous access
|
| gptkbp:sideEffect |
bleeding
hypotension allergic reactions |
| gptkbp:usedFor |
lowering LDL cholesterol
treatment of familial hypercholesterolemia treatment of hyperlipidemia |
| gptkbp:bfsParent |
gptkb:familial_hypercholesterolemia
|
| gptkbp:bfsLayer |
6
|